These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 17017913)

  • 21. Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damage.
    Ferrera D; Mazzaro N; Canale C; Gasparini L
    Neurobiol Aging; 2014 Nov; 35(11):2444-2457. PubMed ID: 24973120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Key Peptides and Proteins in Alzheimer's Disease.
    Penke B; Bogár F; Paragi G; Gera J; Fülöp L
    Curr Protein Pept Sci; 2019; 20(6):577-599. PubMed ID: 30605056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amyloid β precursor protein as a molecular target for amyloid β--induced neuronal degeneration in Alzheimer's disease.
    Bignante EA; Heredia F; Morfini G; Lorenzo A
    Neurobiol Aging; 2013 Nov; 34(11):2525-37. PubMed ID: 23714735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease.
    Li S; Jin M; Liu L; Dang Y; Ostaszewski BL; Selkoe DJ
    Acta Neuropathol Commun; 2018 Nov; 6(1):121. PubMed ID: 30409172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Single Toxin Origin of Alzheimer's Disease and Other Neurodegenerative Disorders Enables Targeted Approach to Treatment and Prevention.
    Tolar M; Hey JA; Power A; Abushakra S
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oligomeric amyloid-beta induces MAPK-mediated activation of brain cytosolic and calcium-independent phospholipase A
    Palavicini JP; Wang C; Chen L; Hosang K; Wang J; Tomiyama T; Mori H; Han X
    Acta Neuropathol Commun; 2017 Jul; 5(1):56. PubMed ID: 28750656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the Expression of Amyloid Precursor Protein and the Ratio of Secreted Amyloid Beta 42 to Amyloid Beta 40 in SH-SY5Y Cells Stably Transfected with Wild-Type, Single-Mutant and Double-Mutant Forms of the APP Gene for the Study of Alzheimer's Disease Pathology.
    Pahrudin Arrozi A; Shukri SNS; Wan Ngah WZ; Mohd Yusof YA; Ahmad Damanhuri MH; Makpol S
    Appl Biochem Biotechnol; 2017 Nov; 183(3):853-866. PubMed ID: 28417423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The redox chemistry of the Alzheimer's disease amyloid beta peptide.
    Smith DG; Cappai R; Barnham KJ
    Biochim Biophys Acta; 2007 Aug; 1768(8):1976-90. PubMed ID: 17433250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Docosahexaenoic acid protects from amyloid and dendritic pathology in an Alzheimer's disease mouse model.
    Cole GM; Frautschy SA
    Nutr Health; 2006; 18(3):249-59. PubMed ID: 17180870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alzheimer’s disease, cerebrovascular disease, and the β-amyloid cascade.
    Honjo K; Black SE; Verhoeff NP
    Can J Neurol Sci; 2012 Nov; 39(6):712-28. PubMed ID: 23227576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
    Hashimoto M; Rockenstein E; Crews L; Masliah E
    Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease.
    Barage SH; Sonawane KD
    Neuropeptides; 2015 Aug; 52():1-18. PubMed ID: 26149638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The inside-out amyloid hypothesis and synapse pathology in Alzheimer's disease.
    Gouras GK; Willén K; Faideau M
    Neurodegener Dis; 2014; 13(2-3):142-6. PubMed ID: 24080821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aβ toxicity in Alzheimer's disease.
    Cavallucci V; D'Amelio M; Cecconi F
    Mol Neurobiol; 2012 Apr; 45(2):366-78. PubMed ID: 22415442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondrial Dysfunction Contributes to the Pathogenesis of Alzheimer's Disease.
    Cabezas-Opazo FA; Vergara-Pulgar K; Pérez MJ; Jara C; Osorio-Fuentealba C; Quintanilla RA
    Oxid Med Cell Longev; 2015; 2015():509654. PubMed ID: 26221414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early-life stress lastingly alters the neuroinflammatory response to amyloid pathology in an Alzheimer's disease mouse model.
    Hoeijmakers L; Ruigrok SR; Amelianchik A; Ivan D; van Dam AM; Lucassen PJ; Korosi A
    Brain Behav Immun; 2017 Jul; 63():160-175. PubMed ID: 28027926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The beta-amyloid cascade hypothesis: a sequence of events leading to neurodegeneration in Alzheimer's disease].
    Kowalska A
    Neurol Neurochir Pol; 2004; 38(5):405-11. PubMed ID: 15565529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On the origin of Alzheimer's disease. Trials and tribulations of the amyloid hypothesis.
    Castello MA; Soriano S
    Ageing Res Rev; 2014 Jan; 13():10-2. PubMed ID: 24252390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting Abeta and tau in Alzheimer's disease, an early interim report.
    Golde TE; Petrucelli L; Lewis J
    Exp Neurol; 2010 Jun; 223(2):252-66. PubMed ID: 19716367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.